
Quick Links
You are about to leave www.astellas.com and enter a third-party website. Astellas is not responsible for the content or services on the third-party website.
Would you like to continue?
Astellas is committed to providing timely and accurate information about our business, science and products. This section offers global resources for investors, journalists and media professionals. News and resources from our local affiliates can be viewed in the Local news section. If you are not an investor or journalist, click here.
TOKYO , April 6, 2020 - Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) and BANDAI NAMCO Entertainment Inc. (President and CEO: Yasuo Miyakawa, “BANDAI NAMCO Entertainment”) today announced that the two companies have entered into an agreement to co-develop an exercise support application for smartphones and other devices to support regular exercise, through the provision of scientifically evidenced exercise programs with game elements, for planned pilot marketing.
In October 2018, Astellas and BANDAI NAMCO Entertainment entered into an agreement and have co-developed an exercise support application for the purposes of medical and health research . Under the terms of the newly executed agreement, the two companies will advance co-development of the application for pilot marketing etc. as follows, based upon the results obtained thus far.
Implementation of medical and health research by Astellas:
Co-development of application for pilot marketing:
Astellas and BANDAI NAMCO Entertainment will decide whether they start the pilot marketing of the application based on the results of the scientific evaluation of the exercise programs in the above-mentioned medical and health research.
Click below for a copy of the full press release